Positive 68Ga-DOTATOC-PET/CT after cortisol level control during ketoconazole treatment in a patient with liver metastases from a pancreatic neuroendocrine tumor and ectopic Cushing syndrome

Endocrine

Volumn 49, Issue 2, 2015, Pages 566-567

  Davi’, Maria Vittoria ^a   Salgarello, Matteo ^b   Francia, Giuseppe ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; DOTATOC GA 68; EVEROLIMUS; HYDROCORTISONE; KETOCONAZOLE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; EDOTREOTIDE; GALLIUM; OCTREOTIDE;

ADRENALECTOMY; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CUSHING SYNDROME; DISEASE ASSOCIATION; DRUG EFFICACY; FOLLOW UP; HUMAN; LIVER METASTASIS; MALE; PANCREAS SURGERY; PANCREATIC NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; SPLEEN SURGERY; SPLENOPANCREASECTOMY; ANALOGS AND DERIVATIVES; BLOOD; COMPUTER ASSISTED TOMOGRAPHY; LIVER TUMOR; MIDDLE AGED; MULTIMODAL IMAGING; PANCREAS TUMOR; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; RADIOGRAPHY; SCINTISCANNING;

CUSHING SYNDROME; GALLIUM RADIOISOTOPES; HUMANS; HYDROCORTISONE; KETOCONAZOLE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; OCTREOTIDE; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84942303238     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-014-0391-y     Document Type: Article

References (3)

1. C. de Bruin, R.A. Feelders, A.M. Waaijers, P.M. van Koetsveld, D.M. Sprij-Mooij, S.W. Lamberts, L.J. Hofland, Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro. J. Mol. Endocrinol. 42, 47–56 (2009)
2. J. van der Hoek, M. Waaijers, P.M. van Koetsveld, D. Sprij-Mooij, R.A. Feelders, H.A. Schmid, P. Schoeffter, D. Hoyer, D. Cervia, J.E. Taylor, M.D. Culler, S.W. Lamberts, L.J. Hofland, Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells. Am. J. Physiol. 289, E278–E287 (2005)
3. C. de Bruin, L.J. Hofland, L.K. Nieman, P.M. van Koetsveld, A.M. Waaijers, D.M. Sprij-Mooij, M. van Essen, S.W. Lamberts, W.W. de Herder, R.A. Feelders, Mifepristone effects on tumor somatostatin receptor expression in two patients with cushing’s syndrome due to ectopic adrenocorticotropin secretion. J. Clin. Endocrinol. Meta. 97(2), 455–462 (2012)